FN2 Earnings Intelligence
Insulet Corp. financials
Insulet Corp. (PODD) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $806.4 | $689.7 | $704.2 | $953.4 | $716.1 | - | - |
| + Debt | - | - | - | $159.3 | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $1,098.8 | $1,305.3 | $1,697.1 | $2,071.6 | $2,708.1 | $3,324.6 | $3,935.5 |
| % Growth | 21.5% | 18.8% | 30.0% | 22.1% | 30.7% | 22.8% | 18.4% |
| Gross Profit | $752.1 | $805.6 | $1,159.9 | $1,445.7 | $1,939.9 | - | - |
| % Margin | 68.4% | 61.7% | 68.3% | 69.8% | 71.6% | - | - |
| EBITDA | $183.4 | $100.8 | $292.8 | $389.7 | $564.2 | - | - |
| % Margin | 16.7% | 7.7% | 17.3% | 18.8% | 20.8% | - | - |
| Net Income | $16.8 | $4.6 | $206.3 | $418.3 | $247.1 | - | - |
| % Margin | 1.5% | 0.4% | 12.2% | 20.2% | 9.1% | - | - |
| Diluted EPS | $0.24 | $0.07 | $2.94 | $5.78 | $3.48 | $6.48 | $8.05 |
| % Growth | 140.0% | -70.8% | 4,100.0% | 96.6% | -39.8% | 86.3% | 24.3% |
| Operating Cash Flow | -$68.1 | $119 | $145.7 | $430.3 | $569.3 | - | - |
| CapEx | $111.9 | $122.9 | $75.6 | $124.9 | $191.6 | - | - |
| Free Cash Flow | -$180 | -$3.9 | $70.1 | $305.4 | $377.7 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $1,098.8 | $1,305.3 | $1,697.1 | $2,071.6 | $2,708.1 | $3,324.6 | $3,935.5 |
| Gross Profit | $752.1 | $805.6 | $1,159.9 | $1,445.7 | $1,939.9 | - | - |
| EBITDA | $183.4 | $100.8 | $292.8 | $389.7 | $564.2 | - | - |
| Net Income | $16.8 | $4.6 | $206.3 | $418.3 | $247.1 | - | - |
| Diluted EPS | $0.24 | $0.07 | $2.94 | $5.78 | $3.48 | $6.48 | $8.05 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $806.4 | $689.7 | $704.2 | $953.4 | $716.1 |
| Short-term Debt | - | - | - | $12.2 | - |
| Long-term Debt | $1,248.8 | $1,374.3 | $147.1 | $147.1 | - |
| Total Debt | - | - | - | $159.3 | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$68.1 | $119 | $145.7 | $430.3 | $569.3 |
| Capital Expenditure | $111.9 | $122.9 | $75.6 | $124.9 | $191.6 |
| Free Cash Flow | -$180 | -$3.9 | $70.1 | $305.4 | $377.7 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 21.5% | 18.8% | 30.0% | 22.1% | 30.7% |
| Gross Margin | 68.4% | 61.7% | 68.3% | 69.8% | 71.6% |
| EBITDA Margin | 16.7% | 7.7% | 17.3% | 18.8% | 20.8% |
| Net Margin | 1.5% | 0.4% | 12.2% | 20.2% | 9.1% |
| FCF Margin | -16.4% | -0.3% | 4.1% | 14.7% | 13.9% |
| Diluted EPS Growth | 140.0% | -70.8% | 4,100.0% | 96.6% | -39.8% |